Lintuzumab

(Synonyms: SGN-33; HuM-195; GLK-33 Antibody)
Kundenbewertung

Based on 1 Customer Validation

Lintuzumab (HUM-195) is an anti-CD33 humanized monoclonal antibody. Lintuzumab reduces the production of TNFα-induced pro-inflammatory cytokines and chemokines by AML cells. Lintuzumab promotes tumor cell killing through antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis (ADCP) activities against MDR and MDR+ AML cell lines and primary AML patient samples. Lintuzumab enhances survival and reduces tumor burden in mice.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 98.09%
  • CAS. Nr.: 166089-32-3
  • Molecular Weight:145.24 kDa
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Alle Radionuclide-Drug Conjugates (RDCs) Isoform-spezifische Produkte anzeigen

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00